- Research works
- 82 ▼ 42% vs 2013–17
- Citations
- 2.8k 34.2 per fractional work
- Top-10% rate
- 11.0% record average 16.5%
- Open access
- 52% world 28%
Not ranked overall: Lead Discovery Center (Germany) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Pharmacology, Toxicology and Pharmaceutics, 13.3×. Every wedge is a field page.
- Pharmacology, Toxicology and Pharmaceutics 13.3×
- Immunology and Microbiology 10.1×
- Biochemistry, Genetics and Molecular Biology 5.3×
- Chemistry 2.7×
- Neuroscience 2.3×
- Medicine 1.3×
- Computer Science 1.2×
- Engineering 0.5×
- Social Sciences 0.4×
- Earth and Planetary Sciences 0.4×
- Health Professions 0.1×
- Business, Management and Accounting 0.1×
Who are the top researchers at Lead Discovery Center (Germany)?
Ranked on the composite score, Bert Klebl lead among researchers whose main affiliation is Lead Discovery Center (Germany).
- 1 Bert Klebl · #1,219,199 worldwide 35 citations · 21 works
Which keywords describe research at Lead Discovery Center (Germany)?
By fractional works in all years, weighted toward what it does more of than the world: Cancer Therapy, Drug Discovery, Cancer, Regulation, Medicinal Chemistry, Apoptosis, Molecular Docking and Pharmacokinetics.
- Therapeutics
- Calcium Signaling
- Signal Transduction
- Capacity Building
- Therapeutic Targets
- Endophytic Fungi
- Peptide Synthesis
- p53
- Macrocycles
- Cell Cycle
- Metastatic Breast Cancer
- Breast Cancer
- Pharmacology
- Transcriptional Regulation
- Virtual Screening
- Molecular Docking
- Apoptosis
- Machine Learning
- Regulation
- Cancer
- Cancer Therapy
- Drug Discovery
- Medicinal Chemistry
- Inflammation
- Drug Target Identification
- Pharmacokinetics
- Protein-Protein Interactions
- Cell Signaling
- Mutation
- Gene Expression
- Tumor Suppression
- Immune Response
- Tumor Microenvironment
- Foldamers
- Cell Cycle Control
- Glycosylation
- Oncogenic Mutations
- Marine Natural Products
- CDK4/6 Inhibitors
- Epigenetic Regulation
Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Cancer Therapy9▲ 17×13 topics
- Cancer7▲ 6.2×22 topics
- Drug Discovery7▲ 21×7 topics
- Regulation5▲ 9.3×5 topics
- Medicinal Chemistry4▲ 14×6 topics
- Machine Learning4▲ 2.3×4 topics
- Inflammation4▲ 2.0×19 topics
- Apoptosis4▲ 11×8 topics
- Drug Target Identification4▲ 60×1 topic
- Molecular Docking4▲ 30×2 topics
- Pharmacokinetics4▲ 16×2 topics
- Virtual Screening4▲ 60×1 topic
- Protein-Protein Interactions3▲ 38×3 topics
- Transcriptional Regulation3▲ 15×7 topics
- Cell Signaling3▲ 10×5 topics
- Pharmacology3▲ 11×7 topics
- Mutation3▲ 22×2 topics
- Breast Cancer3▲ 12×3 topics
- Gene Expression3▲ 5.4×9 topics
- Metastatic Breast Cancer3▲ 49×2 topics
- Tumor Suppression3▲ 29×2 topics
- Cell Cycle3▲ 56×1 topic
- Immune Response3▲ 5.1×9 topics
- Macrocycles3▲ 32×2 topics
- Tumor Microenvironment3▲ 9.1×6 topics
- p533▲ 74×1 topic
- Foldamers2▲ 37×1 topic
- Peptide Synthesis2▲ 37×1 topic
- Cell Cycle Control2▲ 111×2 topics
- Endophytic Fungi2▲ 24×2 topics
- Glycosylation2▲ 12×3 topics
- Therapeutic Targets2▲ 11×5 topics
- Oncogenic Mutations2▲ 50×2 topics
- Capacity Building2▲ 30×2 topics
- Marine Natural Products2▲ 38×2 topics
- Signal Transduction2▲ 8.9×3 topics
- CDK4/6 Inhibitors2▲ 127×1 topic
- Calcium Signaling2▲ 16×3 topics
- Epigenetic Regulation2▲ 9.6×5 topics
- Therapeutics2▲ 15×2 topics
Which research topics does Lead Discovery Center (Germany) publish most on?
By volume in 2022–2025: Immune cells in cancer, Ubiquitin and proteasome pathways, Histone Deacetylase Inhibitors Research and PI3K/AKT/mTOR signaling in cancer.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Immune cells in cancer Immunology 1 works
- 2 Ubiquitin and proteasome pathways Molecular Biology 1 works
- 3 Histone Deacetylase Inhibitors Research Molecular Biology 1 works
- 4 PI3K/AKT/mTOR signaling in cancer Molecular Biology 0 works
- 5 Nanoplatforms for cancer theranostics Biomedical Engineering 0 works
- 6 Advanced Database Systems and Queries Computer Networks and Communications 0 works
- 7 14-3-3 protein interactions Molecular Biology 0 works
- 8 Educational Research and Methods Education 0 works
- 9 Arabic Language Education Studies Education 0 works
- 10 Advanced Drug Delivery Systems Pharmaceutical Science 0 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Lead Discovery Center (Germany)'s research output changed?
Output in 2018–2022 was 42% lower than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Dortmund
- TU Dortmund University
- Max Planck Institute of Molecular Physiology
- Leibniz Institute for Analytical Sciences - ISAS
- Dortmund University of Applied Sciences and Arts
- Federal Institute for Occupational Safety and Health
- Klinikum Dortmund
- Leibniz Research Centre for Working Environment and Human Factors
- International School of Management
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.